D. Western Therapeutics Institute Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Yuichi Hidaka
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 16yrs |
CEO ownership | 7.7% |
Management average tenure | no data |
Board average tenure | 10.7yrs |
Recent management updates
Recent updates
CEO
Yuichi Hidaka (51 yo)
16yrs
Tenure
Mr. Yuichi Hidaka has been President of D.Western Therapeutics Institute, Inc.(DWTI) since December 2008 and serves as its Chief Executive Officer. Mr. Hidaka serves as a Director at Actual Eyes Inc. He se...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 16yrs | no data | 7.69% € 3.1m | |
CFO & Director | 1.8yrs | no data | 0.015% € 6.0k | |
Independent Outside Director | 14.8yrs | no data | 0.047% € 19.3k | |
Independent Outside Director | 6.7yrs | no data | 0.00026% € 105.7 | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data |
10.7yrs
Average Tenure
56.5yo
Average Age
Experienced Board: 6DW's board of directors are seasoned and experienced ( 10.7 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/25 11:17 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
D. Western Therapeutics Institute, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|